首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes
【24h】

Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes

机译:一氧化氮抑制内皮细胞衰老:与更年期和糖尿病相关的动脉粥样硬化的意义

获取原文
获取原文并翻译 | 示例
           

摘要

Senescence may contribute to the pathogenesis of atherosclerosis. Although the bioavailability of nitric oxide (NO) is limited in senescence, the effect of NO on senescence and its relationship to cardiovascular risk factors have not been investigated fully. We studied these factors by investigating senescence-associated beta-galactosidase (SA-beta-gal) and human telomerase activity in human umbilical venous endothelial cells (HUVECs). Treatment with NO donor (Z)-1-[2-(2-aminoethyl)-N-(2-aminoethyl)amino]diazen-ium-1,2-diolate (DETA-NO) and transfection with endothelial NO synthase (eNOS) into HUVECs each decreased the number of SA-beta-gal positive cells and increased telomerase activity. The NOS inhibitor N-G-nitro-L-arginine methyl ester (L-NAME) abolished the effect of eNOS transfection. The physiological concentration of 17 beta-estradiol activated hTERT, decreased SA-beta-gal-positive cells, and caused cell proliferation. However, ICI 182780, an estrogen receptor-specific antagonist, and L-NAME each inhibited these effects. Finally, we investigated the effect of NO bioavailability on high glucose-promoted cellular senescence of HUVECs. Inhibition by eNOS transfection of this cellular senescence under high glucose conditions was less pronounced. Treatment with L-arginine or L-citrulline of eNOS-transfected cells partially inhibited, and combination of L-arginine and L-citrulline with antioxidants strongly prevented, high glucose-induced cellular senescence. These data demonstrate that NO can prevent endothelial senescence, thereby contributing to the anti-senile action of estrogen. The ingestion of NO-boosting substances, including L-arginine, L-citrulline, and antioxidants, can delay endothelial senescence under high glucose. We suggest that the delay in endothelial senescence through NO and/or eNOS activation may have clinical utility in the treatment of atherosclerosis in the elderly.
机译:衰老可能与动脉粥样硬化的发病机理有关。尽管一氧化氮(NO)的生物利用度在衰老中受到限制,但尚未充分研究NO对衰老的影响及其与心血管危险因素的关系。我们通过研究与人脐静脉内皮细胞(HUVECs)相关的衰老相关的β-半乳糖苷酶(SA-β-gal)和人类端粒酶活性来研究这些因素。用NO供体(Z)-1- [2-(2-氨基乙基)-N-(2-氨基乙基)氨基]重氮基1,2-二醇盐(DETA-NO)处理并用内皮NO合酶(eNOS)转染)进入HUVEC,每个都减少了SA-β-gal阳性细胞的数量,并增加了端粒酶活性。 NOS抑制剂N-G-硝基-L-精氨酸甲酯(L-NAME)取消了eNOS转染的作用。 17β-雌二醇激活hTERT的生理浓度,减少SA-β-gal阳性细胞,并引起细胞增殖。但是,ICI 182780(一种雌激素受体特异性拮抗剂)和L-NAME均抑制了这些作用。最后,我们研究了NO生物利用度对HUVECs高糖促进的细胞衰老的影响。在高葡萄糖条件下,通过eNOS转染对该细胞衰老的抑制作用不太明显。用L-精氨酸或L-瓜氨酸处理转染eNOS的细胞受到部分抑制,并且将L-精氨酸和L-瓜氨酸与抗氧化剂联合使用可有效防止高糖诱导的细胞衰老。这些数据证明NO可以防止内皮细胞衰老,从而有助于雌激素的抗衰老作用。摄入富含NO的物质(包括L-精氨酸,L-瓜氨酸和抗氧化剂)可延迟高葡萄糖下的内皮细胞衰老。我们建议通过NO和/或eNOS激活延迟内皮细胞衰老可能在治疗老年人的动脉粥样硬化中具有临床效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号